Dijke Esme I, Platt Jeffrey L, Blair Paul, Clatworthy Menna R, Patel Jignesh K, Kfoury A G, Cascalho Marilia
Department of Pediatrics and Alberta Transplant Institute, University of Alberta, Edmonton, Alberta, Canada.
Departments of Surgery and Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan.
J Heart Lung Transplant. 2016 Jun;35(6):704-10. doi: 10.1016/j.healun.2016.01.1232. Epub 2016 Feb 12.
B cell responses underlie the most vexing immunological barriers to organ transplantation. Much has been learned about the molecular mechanisms of B cell responses to antigen and new therapeutic agents that specifically target B cells or suppress their functions are available. Yet, despite recent advances, there remains an incomplete understanding about how B cell functions determine the fate of organ transplants and how, whether or when potent new therapeutics should optimally be used. This gap in understanding reflects in part the realization that besides producing antibodies, B cells can also regulate cellular immunity, contribute to the genesis of tolerance and induce accommodation. Whether non-specific depletion of B cells, their progeny or suppression of their functions would undermine these non-cognate functions and whether graft outcome would suffer as a result is unknown. These questions were discussed at a symposium on "B cells in transplantation" at the 2015 ISHLT annual meeting. Those discussions are summarized here and a new perspective is offered.
B细胞反应是器官移植中最棘手的免疫障碍的基础。关于B细胞对抗原反应的分子机制已经有了很多了解,并且有专门针对B细胞或抑制其功能的新型治疗药物。然而,尽管最近取得了进展,但对于B细胞功能如何决定器官移植的命运,以及如何、是否或何时应最佳地使用有效的新型治疗方法,仍存在不完全的理解。这种理解上的差距部分反映了这样一种认识,即除了产生抗体外,B细胞还可以调节细胞免疫、促进耐受性的产生并诱导适应性改变。B细胞及其后代的非特异性耗竭或其功能的抑制是否会破坏这些非同源功能,以及移植结果是否会因此受到影响尚不清楚。这些问题在2015年国际心脏和肺移植学会(ISHLT)年会上关于“移植中的B细胞”的研讨会上进行了讨论。这里总结了这些讨论,并提供了一个新的视角。